Efficacy and safety of tofacitinib for active rheumatoid arthritis with an inadequate response to methotrexate or disease-modifying antirheumatic drugs: a meta-analysis of randomized controlled trials

BACKGROUND/AIMS: The aim of this study was to assess the efficacy and safety of tofacitinib (5 and 10 mg twice daily) in patients with active rheumatoid arthritis (RA). METHODS: A systematic review of randomized controlled trials (RCTs) that examined the efficacy and safety of tofacitinib in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Gwan Gyu, Bae, Sang-Cheol, Lee, Young Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164730/
https://www.ncbi.nlm.nih.gov/pubmed/25228842
http://dx.doi.org/10.3904/kjim.2014.29.5.656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164730/
https://www.ncbi.nlm.nih.gov/pubmed/25228842
http://dx.doi.org/10.3904/kjim.2014.29.5.656

Ejemplares similares